This year 2022 we are in full growth having incorporated 6 members in the first half of the year. The new partners incorporated at the last meeting on 9 June were: CIC bioGUNE, Ibermática, IES Diagnostics and Nexkin.
Below is a brief description of each of the latest additions:
The Centre for Cooperative Research in Bioscience (CIC bioGUNE) – Member of the Basque Research and Technology Alliance – based in the Bizkaia Science and Technology Park, is a biomedical research organisation that develops cutting-edge research at the interface between structural, molecular and cellular biology, with a special focus on the study of the molecular basis of disease, to be used in the development of new diagnostic methods and advanced therapies.
Ibermática is a global IT services company that has been operating in the market since 1973. Its activity is focused on the areas of consultancy, infrastructure services, integration of information systems, outsourcing and implementation of integrated business management solutions. It is also present in the main sectors of activity (Finance, Insurance, Industry, Services, Telco & Media, Health, Utilities and Public Administration), where it offers sector-specific solutions. Through this wide range of advanced solutions and services, it improves efficiency and drives the digital transformation of organizations.
IES Diagnostics is a biochemical laboratory whose objective is to obtain the most accurate results while improving the user experience. To achieve this, it combines the high level of specialisation and knowledge of a multidisciplinary team with ultra-efficient diagnostic technology. IES Diagnostics brings biomedical knowledge and the most advanced technology to the user in an easy, safe, comfortable and, above all, understandable way.
Nexkin medical offers solutions for the digitalisation of medical practice, specifically for the speciality of allergology. Through the use of electromedical devices and software, Nexkin medical’s solutions allow to digitise processes, improve efficiency and exploit clinical data in the diagnosis, treatment and follow-up of patients.
If you were unable to attend the open meetings organised on 9 June, you can find the video of the event on the Cluster’s channel: